APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-α4β7 Integrin Monoclonal Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-α4β7 Integrin Monoclonal Antibody Industry Growth and Trends Forecast to 2032

Report ID 173964480128 December 202579 pages

Choose your research edition.

Industry ResearchAnti-α4β7 Integrin Monoclonal Antibody Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-α4β7 Integrin Monoclonal Antibody Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Anti-α4β7 Integrin Monoclonal Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-α4β7 Integrin Monoclonal Antibody Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-α4β7 Integrin Monoclonal Antibody Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Anti-α4β7 Integrin Monoclonal Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-α4β7 Integrin Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-α4β7 Integrin Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-α4β7 Integrin Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-α4β7 Integrin Monoclonal Antibody include Biogen, Novartis, Sandoz and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-α4β7 Integrin Monoclonal Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-α4β7 Integrin Monoclonal Antibody market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-α4β7 Integrin Monoclonal Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-α4β7 Integrin Monoclonal Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-α4β7 Integrin Monoclonal Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-α4β7 Integrin Monoclonal Antibody Market by Company

Biogen

Novartis

Sandoz

Takeda

Anti-α4β7 Integrin Monoclonal Antibody Segment by Type

Natalizumub

Vedolizumab

Anti-α4β7 Integrin Monoclonal Antibody Segment by Application

Inflammatory Bowel Disease (IBD)

Multiple Sclerosis (MS)

Other

Anti-α4β7 Integrin Monoclonal Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-α4β7 Integrin Monoclonal Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-α4β7 Integrin Monoclonal Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-α4β7 Integrin Monoclonal Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-α4β7 Integrin Monoclonal Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-α4β7 Integrin Monoclonal Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Natalizumub Table 2. Major Company of Vedolizumab Table 3. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 5. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global Anti-α4β7 Integrin Monoclonal Antibody Price by Type (2021-2026) & (US$/Unit) Table 9. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2027-2032) & (K Units) Table 10. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global Anti-α4β7 Integrin Monoclonal Antibody Price by Type (2027-2032) & (US$/Unit) Table 14. North America Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 15. North America Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 17. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 21. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. Anti-α4β7 Integrin Monoclonal Antibody Industry Trends Table 25. Anti-α4β7 Integrin Monoclonal Antibody Industry Drivers Table 26. Anti-α4β7 Integrin Monoclonal Antibody Industry Opportunities and Challenges Table 27. Anti-α4β7 Integrin Monoclonal Antibody Industry Restraints Table 28. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Anti-α4β7 Integrin Monoclonal Antibody Revenue Market Share by Company (2021-2026) Table 30. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Company (2021-2026) & (K Units) Table 31. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Share by Company (2021-2026) Table 32. Global Anti-α4β7 Integrin Monoclonal Antibody Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Anti-α4β7 Integrin Monoclonal Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anti-α4β7 Integrin Monoclonal Antibody Major Company Production Sites and Headquarters Table 35. Global Anti-α4β7 Integrin Monoclonal Antibody Company, Product Type & Application Table 36. Global Anti-α4β7 Integrin Monoclonal Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Anti-α4β7 Integrin Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anti-α4β7 Integrin Monoclonal Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Region (2021-2026) & (K Units) Table 41. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global Anti-α4β7 Integrin Monoclonal Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Region (2027-2032) & (K Units) Table 46. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global Anti-α4β7 Integrin Monoclonal Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 52. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global Anti-α4β7 Integrin Monoclonal Antibody Price by Application (2021-2026) & (US$/Unit) Table 56. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2027-2032) & (K Units) Table 57. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global Anti-α4β7 Integrin Monoclonal Antibody Price by Application (2027-2032) & (US$/Unit) Table 61. North America Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 62. North America Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 64. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 68. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Biogen Company Information Table 72. Biogen Business Overview Table 73. Biogen Anti-α4β7 Integrin Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Biogen Anti-α4β7 Integrin Monoclonal Antibody Product Portfolio Table 75. Biogen Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Anti-α4β7 Integrin Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novartis Anti-α4β7 Integrin Monoclonal Antibody Product Portfolio Table 80. Novartis Recent Development Table 81. Sandoz Company Information Table 82. Sandoz Business Overview Table 83. Sandoz Anti-α4β7 Integrin Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sandoz Anti-α4β7 Integrin Monoclonal Antibody Product Portfolio Table 85. Sandoz Recent Development Table 86. Takeda Company Information Table 87. Takeda Business Overview Table 88. Takeda Anti-α4β7 Integrin Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Takeda Anti-α4β7 Integrin Monoclonal Antibody Product Portfolio Table 90. Takeda Recent Development Table 91. North America Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 93. North America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 94. North America Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 96. North America Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country (2021-2026) Table 99. North America Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Anti-α4β7 Integrin Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 101. Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 103. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 104. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country (2021-2026) Table 109. Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Anti-α4β7 Integrin Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country (2021-2026) Table 119. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 121. Latin America Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 123. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 124. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country (2021-2026) Table 129. Latin America Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Anti-α4β7 Integrin Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country (2021-2026) Table 139. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Anti-α4β7 Integrin Monoclonal Antibody Distributors List Table 144. Anti-α4β7 Integrin Monoclonal Antibody Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Anti-α4β7 Integrin Monoclonal Antibody Image Figure 2. Global Anti-α4β7 Integrin Monoclonal Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-α4β7 Integrin Monoclonal Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-α4β7 Integrin Monoclonal Antibody Sales (2021-2032) & (K Units) Figure 5. Natalizumub Image Figure 6. Global Natalizumub Sales YoY Growth (2021-2032) & (K Units) Figure 7. Vedolizumab Image Figure 8. Global Vedolizumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Anti-α4β7 Integrin Monoclonal Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Anti-α4β7 Integrin Monoclonal Antibody Market Share by Type 2025 VS 2032 Figure 11. North America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Anti-α4β7 Integrin Monoclonal Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Inflammatory Bowel Disease (IBD) Image Figure 24. Global Inflammatory Bowel Disease (IBD) Sales YoY Growth (2021-2032) & (K Units) Figure 25. Multiple Sclerosis (MS) Image Figure 26. Global Multiple Sclerosis (MS) Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Anti-α4β7 Integrin Monoclonal Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Anti-α4β7 Integrin Monoclonal Antibody Market Share by Application 2025 VS 2032 Figure 31. North America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 32. North America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 33. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 34. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 37. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 41. North America Anti-α4β7 Integrin Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Anti-α4β7 Integrin Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Anti-α4β7 Integrin Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Anti-α4β7 Integrin Monoclonal Antibody Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Anti-α4β7 Integrin Monoclonal Antibody Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Natalizumub
  • Vedolizumab
Applications
  • Inflammatory Bowel Disease (IBD)
  • Multiple Sclerosis (MS)
  • Other
Companies covered
  • Biogen
  • Novartis
  • Sandoz
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-α4β7 Integrin Monoclonal Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-α4β7 Integrin Monoclonal Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-α4β7 Integrin Monoclonal Antibody Market by Type
  6. 1.3.1 Natalizumub
  7. 1.3.2 Vedolizumab
  8. 1.4 Global Anti-α4β7 Integrin Monoclonal Antibody Market Size by Type
  9. 1.4.1 Global Anti-α4β7 Integrin Monoclonal Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Anti-α4β7 Integrin Monoclonal Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Anti-α4β7 Integrin Monoclonal Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-α4β7 Integrin Monoclonal Antibody Industry Trends
  2. 2.2 Anti-α4β7 Integrin Monoclonal Antibody Industry Drivers
  3. 2.3 Anti-α4β7 Integrin Monoclonal Antibody Industry Opportunities and Challenges
  4. 2.4 Anti-α4β7 Integrin Monoclonal Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-α4β7 Integrin Monoclonal Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-α4β7 Integrin Monoclonal Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-α4β7 Integrin Monoclonal Antibody Price (2021-2026)
  4. 3.4 Global Anti-α4β7 Integrin Monoclonal Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-α4β7 Integrin Monoclonal Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-α4β7 Integrin Monoclonal Antibody Company, Product Type & Application
  7. 3.7 Global Anti-α4β7 Integrin Monoclonal Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-α4β7 Integrin Monoclonal Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-α4β7 Integrin Monoclonal Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-α4β7 Integrin Monoclonal Antibody Tier 1, Tier 2, and Tier 3
4 Anti-α4β7 Integrin Monoclonal Antibody Regional Status and Outlook
  1. 4.1 Global Anti-α4β7 Integrin Monoclonal Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-α4β7 Integrin Monoclonal Antibody Historic Market Size by Region
  3. 4.2.1 Global Anti-α4β7 Integrin Monoclonal Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-α4β7 Integrin Monoclonal Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-α4β7 Integrin Monoclonal Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-α4β7 Integrin Monoclonal Antibody Forecasted Market Size by Region
  7. 4.3.1 Global Anti-α4β7 Integrin Monoclonal Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-α4β7 Integrin Monoclonal Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-α4β7 Integrin Monoclonal Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-α4β7 Integrin Monoclonal Antibody by Application
  1. 5.1 Anti-α4β7 Integrin Monoclonal Antibody Market by Application
  2. 5.1.1 Inflammatory Bowel Disease (IBD)
  3. 5.1.2 Multiple Sclerosis (MS)
  4. 5.1.3 Other
  5. 5.2 Global Anti-α4β7 Integrin Monoclonal Antibody Market Size by Application
  6. 5.2.1 Global Anti-α4β7 Integrin Monoclonal Antibody Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Anti-α4β7 Integrin Monoclonal Antibody Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Anti-α4β7 Integrin Monoclonal Antibody Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biogen
  2. 6.1.1 Biogen Company Information
  3. 6.1.2 Biogen Business Overview
  4. 6.1.3 Biogen Anti-α4β7 Integrin Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biogen Anti-α4β7 Integrin Monoclonal Antibody Product Portfolio
  6. 6.1.5 Biogen Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Anti-α4β7 Integrin Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Anti-α4β7 Integrin Monoclonal Antibody Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Sandoz
  14. 6.3.1 Sandoz Company Information
  15. 6.3.2 Sandoz Business Overview
  16. 6.3.3 Sandoz Anti-α4β7 Integrin Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sandoz Anti-α4β7 Integrin Monoclonal Antibody Product Portfolio
  18. 6.3.5 Sandoz Recent Developments
  19. 6.4 Takeda
  20. 6.4.1 Takeda Company Information
  21. 6.4.2 Takeda Business Overview
  22. 6.4.3 Takeda Anti-α4β7 Integrin Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Takeda Anti-α4β7 Integrin Monoclonal Antibody Product Portfolio
  24. 6.4.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Anti-α4β7 Integrin Monoclonal Antibody Sales by Country
  2. 7.1.1 North America Anti-α4β7 Integrin Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country
  6. 7.2.1 North America Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-α4β7 Integrin Monoclonal Antibody Sales by Country
  2. 8.1.1 Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country
  6. 8.2.1 Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales by Country
  2. 9.1.1 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-α4β7 Integrin Monoclonal Antibody Sales by Country
  2. 10.1.1 South America Anti-α4β7 Integrin Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country
  6. 10.2.1 South America Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales by Country
  2. 11.1.1 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-α4β7 Integrin Monoclonal Antibody Value Chain Analysis
  2. 12.1.1 Anti-α4β7 Integrin Monoclonal Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-α4β7 Integrin Monoclonal Antibody Production Mode & Process
  7. 12.2 Anti-α4β7 Integrin Monoclonal Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-α4β7 Integrin Monoclonal Antibody Distributors
  10. 12.2.3 Anti-α4β7 Integrin Monoclonal Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst